Back
Ultragenyx Pharmaceutical Stock Price Chart
Economic Policy Shifts = Huge Market Opportunity
See which of your stocks make the grade - analyze 3 stocks FREE.
Sell
39
RARE
Ultragenyx Pharmaceutical
Last Price:
$37.20
Seasonality Move:
8.27%
7 Day Trial
ALL ACCESS PASS
$
7
Here's the Best Day to Buy Nvidia
Click here to see the green days for 5 major stocks today.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight buying pressure.
Ultragenyx Pharmaceutical Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.83 | Buy |
| 20-day SMA: | 35.68 | Buy |
| 50-day SMA: | 35.79 | Buy |
| 200-day SMA: | 45.09 | Sell |
| 8-day EMA: | 36.27 | Buy |
| 20-day EMA: | 36 | Buy |
| 50-day EMA: | 36.7 | Buy |
| 200-day EMA: | 41.61 | Sell |
Ultragenyx Pharmaceutical Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 55.65 | Buy |
| Chaikin Money Flow: | 332186 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.52 - 37.18) | Buy |
| Bollinger Bands (100): | (35.2 - 42.4) | Sell |
Ultragenyx Pharmaceutical Technical Analysis
| May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 23 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Ultragenyx Pharmaceutical Stock
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.17 while RARE 8-day simple moving average is 35.83, which is a Buy signal.
-
The stock price of RARE is 37.17 while Ultragenyx Pharmaceutical 20-day SMA is 35.68, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day simple moving average is 35.79 while RARE share price is 37.17, making it a Buy technically.
-
RARE stock price is 37.17 and Ultragenyx Pharmaceutical 200-day simple moving average is 45.09, creating a Sell signal.
RARE Technical Analysis vs Fundamental Analysis
Sell
39
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy or a Sell?
-
Ultragenyx Pharmaceutical stock is rated a SellThe current Ultragenyx Pharmaceutical [RARE] share price is $37.17. The Score for RARE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Ultragenyx Pharmaceutical Stock Info
Market Cap:
3.5B
Price in USD:
37.17
Share Volume:
930.3K
Ultragenyx Pharmaceutical 52-Week Range
52-Week High:
60.37
52-Week Low:
29.59
Sell
39
Ultragenyx Pharmaceutical (RARE)
is a Sell
Ultragenyx Pharmaceutical Share Price Forecast
-
What is the Ultragenyx Pharmaceutical stock price today?The Ultragenyx Pharmaceutical stock price is 37.17 USD today.
-
Will RARE stock go up or go down?Ultragenyx Pharmaceutical> share price is forecast to RISE/FALL based on technical indicators
-
Is Ultragenyx Pharmaceutical overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ultragenyx Pharmaceutical is overvalued.
Is Ultragenyx Pharmaceutical Stock a Buy?
-
Ultragenyx Pharmaceutical share price is 37.17 while RARE 8-day exponential moving average is 36.27, which is a Buy signal.
-
The stock price of RARE is 37.17 while Ultragenyx Pharmaceutical 20-day EMA is 36.00, which makes it a Buy.
-
Ultragenyx Pharmaceutical 50-day exponential moving average is 36.70 while RARE share price is 37.17, making it a Buy technically.
-
RARE stock price is 37.17 and Ultragenyx Pharmaceutical 200-day simple moving average is 41.61, creating a Sell signal.
Fundamental Analysis of Ultragenyx Pharmaceutical
Is Ultragenyx Pharmaceutical a good investment?
-
Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.37 per share, an increase this year of $0.84 per share, and an increase next year of $1.76 per share.
Technical Analysis of Ultragenyx Pharmaceutical
Should I short Ultragenyx Pharmaceutical stock?
-
RARE Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Ultragenyx Pharmaceutical is a Buy
-
Ultragenyx Pharmaceutical Relative Strength Index (RSI) is 55.65, which suggest Ultragenyx Pharmaceutical is overbought
-
The Bollinger Bands (25) for Ultragenyx Pharmaceutical is (34.52 - 37.18), which suggest Ultragenyx Pharmaceutical is a Sell
-
The Bollinger Bands (100) for Ultragenyx Pharmaceutical is (35.2 - 42.4), which suggest Ultragenyx Pharmaceutical is a Sell
* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.